For example, the missense variant rs1800729 in TSC2 was exclusively present in CLL (eight cases), and the missense variant rs139075637 in POLE was exclusively present in non-CLL B lymphoid tumors (seven cases). This evidence concerns the gene POLE and B-cell chronic lymphocytic leukemia.